Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Raquel Pérez-Barquín"'
Autor:
Jon Zubiaur, Alba Herrero-Morant, Adrián Margarida de Castro, Raquel Pérez-Barquín, Ivan Ferraz-Amaro, Javier Loricera, Santos Castañeda, Ricardo Blanco
Publikováno v:
European Journal of Internal Medicine. 112:70-76
Autor:
Andrea Teira Calderón, Ignacio Santiago Setién, Ramón Teira Cobo, Cristina Abad Pérez, Indira Cabrera Rubio, Manuel Lozano González, Jon Zubiaur Zamacola, Adrián Margarida de Castro, Raquel Pérez Barquín, Ana de Malet Pintos-Fonseca, José Antonio Vázquez de Prada Tiffe, Jose María de la Torre Hernández, Francisco González Vilchez
Publikováno v:
REC: CardioClinics.
Publikováno v:
Annals of the Rheumatic Diseases; 2022 Supplement, Vol. 81, p453-1135, 683p
Publikováno v:
Annals of the Rheumatic Diseases; 2021 Supplement, Vol. 80, p401-1035, 635p
Autor:
Askanase, A., D'cruz, D., Kalunian, K., Merrill, J., Navarra, S., Cahuzac, C., Cornelisse, P., Strasser, D., Trokan, L., Berkani, O.
Publikováno v:
Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p903-904, 2p
Autor:
Herrero-Morant, A., Zubiaur-Zamacola, J., Margarida-de Castro, A., Pérez-Barquín, R., Blanco, R.
Publikováno v:
Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p904-904, 1/3p
Autor:
Vidal, D., Giuponni, J., Guerini, L., Larroulet, R. C., Galindo, M. S., Farfan, J., Arispe, M., Vilca, I., Franco, L., Gomez, V. Ochoa Y., Marcantoni, M., Deves, V., Pradier, F. Zunino, Rama, M. E., Yesuron, G., Walsh, C. Torres, Pintos, I., Duarte, V., Espada, G.
Publikováno v:
Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p678-678, 2/3p
Autor:
A. Herrero-Morant, J. Zubiaur-Zamacola, A. Margarida-de Castro, R. Pérez-Barquín, M. Á. González-Gay, R. Blanco
Publikováno v:
Annals of the Rheumatic Diseases. 81:641.1-641
BackgroundHydroxychloroquine (HCQ) is a widely used drug in Systemic Lupus Erythematosus (SLE). It may cause cardiac alterations which includes short term arrhythmic events (via QT interval prolongation) and medium-late term dose dependent cardiomyop
Autor:
J. Zubiaur-Zamacola, R. Pérez-Barquín, M. A. González-Gay, A. Herrero-Morant, Roman Blanco, A. Margarida-de Castro
Publikováno v:
Annals of the Rheumatic Diseases. 80:966.3-967
Background:Hydroxychloroquine (HCQ) is an extensively used drug in immune-mediated diseases (IMID). Despite its general safety, HCQ can cause serious toxicity such as heart conduction disorders. Atrioventricular block (AVB) is an underrecognized adve
Autor:
J. Zubiaur-Zamacola, Roman Blanco, A. Herrero-Morant, R. Pérez-Barquín, M. A. González-Gay, A. Margarida-de Castro
Publikováno v:
Annals of the Rheumatic Diseases. 80:601.1-601
Background:Hydroxychloroquine (HCQ) is a widely used drug especially in connective tissue disorders such as Systemic Lupus Erythematosus (SLE). Cardiac adverse effects of long-term use of HCQ remains controversial.Objectives:To assess cardiac adverse